Cline Scientific AB (OSTO:CLINE B) Stock Based Compensation: kr0.00 Mil (TTM As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:CLINE B Cline Scientific AB OSTO:CLINE B
4 GF Score
Price kr0.07
View Full Analysis

What is Cline Scientific AB Stock Based Compensation?

Cline Scientific AB OSTO:CLINE B 4 Stock Based Compensation is kr0.00 Mil as of Dec. 2023. GuruFocus rates OSTO:CLINE B with a GF Score™ of 4/100.

Cline Scientific AB's Stock Based Compensation for the six months ended in Dec. 2023 was kr0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00 Mil.

Cline Scientific AB Stock Based Compensation Related Terms

Cline Scientific AB Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Cline Scientific AB's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cline Scientific AB Stock Based Compensation Chart

Cline Scientific AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cline Scientific AB Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:CLINE B
4GF Score
Cline Scientific AB OSTO:CLINE B
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cline Scientific AB Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

What does a Stock Based Compensation of kr0.00 Mil mean?
Cline Scientific AB (OSTO:CLINE B) has a Stock Based Compensation of kr0.00 Mil as of Dec. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Cline Scientific AB and its competitors.
Is Cline Scientific AB's Stock Based Compensation too high?
Cline Scientific AB's current Stock Based Compensation is kr0.00 Mil. Overall, Cline Scientific AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Cline Scientific AB's Stock Based Compensation compare to VRTX and REGN?
Cline Scientific AB's Stock Based Compensation of kr0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Cline Scientific AB and its competitors. Cline Scientific AB's current Stock Based Compensation is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cline Scientific AB stock overvalued right now?
Cline Scientific AB (OSTO:CLINE B) has a current Stock Based Compensation of kr0.00 Mil. The current Stock Based Compensation is kr0.00 Mil. Cline Scientific AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Cline Scientific AB (OSTO:CLINE B), the current Stock Based Compensation is kr0.00 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cline Scientific AB Business Description

Address Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.
4GF Score

Get the complete analysis for OSTO:CLINE B

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.07
Price